Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Comparison: Hormonal Pathways and Hair Follicle Impact

To make this clearer, let's look at a side-by-side comparison. This visual breakdown really highlights the fundamental differences in how these compounds interact with the body's systems related to hair. MK-677 (Ibutamoren) Ghrelin Receptor Agonist; GH Secreta

This comparison does not assign a generated winner or score.

  • To make this clearer, let's look at a side-by-side comparison. This visual breakdown really highlights the fundamental differences in how these compounds interact with the body's systems related to hair.
  • MK-677 (Ibutamoren)
  • Ghrelin Receptor Agonist; GH Secretagogue
  • None / Negligible
  • Significant Increase
  • Neutral to Potentially Positive (via IGF-1)
  • Testosterone
  • Binds to Androgen Receptors; Precursor to DHT
  • Directly Increases
  • Minor Increase
  • Negative (via DHT-induced miniaturization)
  • Finasteride
  • 5-alpha Reductase Inhibitor
  • Significant Decrease
  • Positive (by blocking DHT formation)
  • As you can see, MK-677 operates in a completely different universe than the androgens that cause hair loss and the drugs used to treat it. Its primary impact is on the GH/IGF-1 axis, which is generally considered favorable for hair growth.
More references

Related material